Kerui Medical (301087.SZ): Basically achieved independent research and development and production of core product categories, currently self-production accounts for approximately 60%.

Gelonghui Finance · Nov 8 15:12

Gelonghui November 8th丨KeFu Medical (301087.SZ) accepted a survey from specific parties on November 7, 2024, regarding the proportion of self-produced and agency products, the company's rich product categories, and how to manage inventory effectively. The company mentioned that it has basically achieved independent research and development and production of core product categories, with a current self-production ratio of about 60% and agency ratio of about 20%. The main agency products are hearing aids and physiotherapy devices. The company operates its channels independently, allowing for timely optimization of inventory management based on market and order changes to respond to market fluctuations and customer demands.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

可孚医疗(301087.SZ)：基本实现核心品类的自主研发和生产，目前自产比例约60%

Kerui Medical (301087.SZ): Basically achieved independent research and development and production of core product categories, currently self-production accounts for approximately 60%.

Risk Disclaimer

Statement